Peptides DB
Research-centric peptide and protocol reference hub

Cerebrolysin vs HGH (Somatropin)

Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team

Cerebrolysin: Research use — not FDA-approvedHGH (Somatropin): FDA-approved

A data-driven comparison of Cerebrolysin and HGH (Somatropin) (also searched as HGH (Somatropin) vs Cerebrolysin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

Cerebrolysin centers on neuro, while HGH (Somatropin) leans toward muscle. On indexed research, HGH (Somatropin) is ahead (Cerebrolysin: 20 studies, Human clinical; HGH (Somatropin): 55, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • Cerebrolysin is strongest for neuro; HGH (Somatropin) for muscle.
  • Evidence: Cerebrolysin Human clinical (20 studies) vs HGH (Somatropin) Human clinical (55).
  • Check the FDA-approval status chips above before assuming a legal use pathway.

Effect profiles, overlaid

CerebrolysinHGH (Somatropin)

At a glance

CerebrolysinHuman clinical

Neuroprotective | Stroke recovery and dementia

Strongest: NeuroStudies: 20Level: Well Studied
HGH (Somatropin)Human clinical

Growth stimulation | Growth hormone deficiency

Strongest: MuscleStudies: 55Level: FDA Approved

Cerebrolysin vs HGH (Somatropin): side-by-side

MetricCerebrolysinHGH (Somatropin)
ClassNeuroHealing
Regulatory statusResearch use onlyFDA-approved
Evidence gradeHuman clinicalHuman clinical
Studies indexed2055
Research levelWell StudiedFDA Approved
Strongest effectNeuro & moodMuscle & body comp
Healing & recovery3.04.0
Muscle & body comp0.05.0
Metabolic & appetite0.04.0
Neuro & mood5.02.0
Sleep & circadian0.02.0
Inflammation & immune2.03.0
Skin & aesthetics0.04.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyCerebrolysinHGH (Somatropin)
MechanismNeurotrophic and neuroprotective effectsIGF-1 activation
RouteIntravenous or intramuscular injectionSubcutaneous injection
Half-life~20 min
Time to peak3–6 hours
Duration of actionvariable

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is Cerebrolysin?

Cerebrolysin is a porcine brain-derived peptide preparation studied for stroke recovery, dementia, and TBI, with proposed neurotrophic and neuroprotective effects on the central nervous system.

Full Cerebrolysin profile, mechanism & studies →

What is HGH (Somatropin)?

HGH (somatropin) is recombinant human growth hormone, FDA-approved for pediatric and adult GH deficiency and several wasting and short-stature conditions; widely studied for body composition off-label.

Full HGH (Somatropin) profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingHGH (Somatropin)4.0/5 effect signal
MuscleHGH (Somatropin)5.0/5 effect signal
MetabolicHGH (Somatropin)4.0/5 effect signal
NeuroCerebrolysin5.0/5 effect signal
SleepHGH (Somatropin)2.0/5 effect signal
InflammationHGH (Somatropin)3.0/5 effect signal
SkinHGH (Somatropin)4.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack Cerebrolysin and HGH (Somatropin)?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

Cerebrolysin vs HGH (Somatropin): side effects

Cerebrolysin

No community-reported effects logged yet.

HGH (Somatropin)

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

Cerebrolysin has 20 approved studies indexed (Human clinical), and HGH (Somatropin) has 55 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is Cerebrolysin or HGH (Somatropin) better?

It depends on your goal. Cerebrolysin is strongest for neuro; HGH (Somatropin) for muscle. HGH (Somatropin) has more indexed studies (55). See the goal-by-goal breakdown above.

Is Cerebrolysin or HGH (Somatropin) better for weight loss?

HGH (Somatropin) shows the stronger metabolic & appetite profile (4.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.

Is Cerebrolysin or HGH (Somatropin) better for muscle?

HGH (Somatropin) leads on the muscle & body-composition axis (5.0/5).

Which has more research, Cerebrolysin or HGH (Somatropin)?

Cerebrolysin has 20 approved studies indexed (Human clinical); HGH (Somatropin) has 55 (Human clinical). Higher counts mean more to read, not proven superiority.

Can you stack Cerebrolysin and HGH (Somatropin)?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of Cerebrolysin vs HGH (Somatropin)?

Cerebrolysin: no community-reported effects logged yet. HGH (Somatropin): none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is Cerebrolysin or HGH (Somatropin) FDA-approved?

Cerebrolysin is a research-use compound and is not FDA-approved. HGH (Somatropin) is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is HGH (Somatropin) better than Cerebrolysin?

For muscle, HGH (Somatropin) has the edge; for neuro, Cerebrolysin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.